# Sinocare invests USD7.9 million in EoFlow for diabetic sensor-pump JV

Sinocare will invest KRW9.2 billion (USD7.9 million) in EoFlow for a 1.5% stake and form a joint venture in Changsha, China, to integrate blood glucose monitoring with insulin pumps.

- Type: Investment
- Announced: 2021-10-27
- Where: Changsha, China
- Value: $7.90M
- Status: announced
- Products: blood glucose monitoring system, insulin pump
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Sinocare](https://endata.com/companies/29571.md)
- [EOFlow](https://endata.com/companies/55385.md) (partner)

## Sources

- [yicaiglobal.com](https://www.yicaiglobal.com/news/sinocare-pours-usd79-million-into-eoflow-to-develop-a-diabetic-sensor-pump-solution), 2021-10-27: "Sinocare intends to invest KRW9.2 billion (USD7.9 million) in South Korean insulin pump producer EoFlow and set up a joint venture in central China."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.